“Integrated Safety Analysis of Ruxolitinib Cream: Data From 20 Clinical Studies in Inflammatory Dermatologic Conditions”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 6, Nov. 2025, p. s711, https://doi.org/10.25251/36mxmk39.